Literature DB >> 14566084

Role of protease-activated receptors in the vascular system.

Katsuya Hirano1, Hideo Kanaide.   

Abstract

Thrombin is one of the key molecules involved in the development of vascular diseases. Thrombin does not only serve as a coagulation factor, but it also exerts cellular effects by activating protease (proteinase)-activated receptors (PARs), a family of seven-transmembrane G protein-coupled receptors. This study focused on the role of PARs in the vascular system. Among the four members so far identified, PAR-1 and PAR-2 were found to play an important role in the vascular system, while the functional roles of PAR-3 and PAR-4 appear to be mostly limited to platelets. The endothelial cells play a primary role in mediating the vascular effects of PARs under physiological conditions, while PARs of the smooth muscle cells can be induced under pathological conditions, and therefore play a more pathophysiological role. PAR-1 and PAR-2 mediate various vascular effects including regulation of vascular tone, proliferation and hypertrophy of smooth muscle and angiogenesis. Since proteases are activated under pathological conditions such as hemorrhage, tissue damage, and inflammation, PARs are suggested to play a critical role in the development of functional and structural abnormality in the vascular lesion. Understanding the functional role of PARs in the vascular system can thus help in the development of new strategies for the prevention and therapy of vascular diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14566084     DOI: 10.5551/jat.10.211

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  27 in total

1.  Antiplatelet and antithrombotic effect of F 16618, a new thrombin proteinase-activated receptor-1 (PAR1) antagonist.

Authors:  M Dumas; F Nadal-Wollbold; P Gaussem; M Perez; T Mirault; R Létienne; T Bourbon; F Grelac; B Le Grand; C Bachelot-Loza
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  Effects of protease-activated receptors (PARs) on intracellular calcium dynamics of acinar cells in rat lacrimal glands.

Authors:  Makoto Oikawa; Tomoyuki Saino; Katsura Kimura; Yuki Kamada; Yasunori Tamagawa; Daijiro Kurosaka; Yoh-ichi Satoh
Journal:  Histochem Cell Biol       Date:  2013-03-06       Impact factor: 4.304

3.  Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization.

Authors:  Joseph N McLaughlin; Myla M Patterson; Asrar B Malik
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-21       Impact factor: 11.205

4.  Nox1 transactivation of epidermal growth factor receptor promotes N-cadherin shedding and smooth muscle cell migration.

Authors:  Dammanahalli K Jagadeesha; Maysam Takapoo; Botond Banfi; Ramesh C Bhalla; Francis J Miller
Journal:  Cardiovasc Res       Date:  2011-11-18       Impact factor: 10.787

5.  Up-regulation of proteinase-activated receptor 1 and increased contractile responses to thrombin after subarachnoid haemorrhage.

Authors:  Y Maeda; K Hirano; Y Kai; M Hirano; S O Suzuki; T Sasaki; H Kanaide
Journal:  Br J Pharmacol       Date:  2007-09-03       Impact factor: 8.739

6.  B2 kinin receptor activation is the predominant mechanism by which trypsin mediates endothelium-dependent relaxation in bovine coronary arteries.

Authors:  Grant R Drummond; Stavros Selemidis; Thomas M Cocks
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-05-06       Impact factor: 3.000

7.  Changes in amniotic fluid concentration of thrombin-antithrombin III complexes in patients with preterm labor: evidence of an increased thrombin generation.

Authors:  Offer Erez; Roberto Romer; Edi Vaisbuch; Tinnakorn Chaiworapongsa; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Francesca Gotsch; Ricardo Gomez; Eli Maymon; Percy Pacora; Samuel S Edwin; Chong Jai Kim; Nandor Gabor Than; Pooja Mittal; Lami Yeo; Zhong Dong; Bo Hyun Yoon; Sonia S Hassan; Moshe Mazor
Journal:  J Matern Fetal Neonatal Med       Date:  2009-11

8.  Matrix metalloproteinase-1 and thrombin differentially activate gene expression in endothelial cells via PAR-1 and promote angiogenesis.

Authors:  Jessica S Blackburn; Constance E Brinckerhoff
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

9.  Evidence that protease activated receptor 2 expression is enhanced in human coronary atherosclerotic lesions.

Authors:  C Napoli; F de Nigris; J L Wallace; M D Hollenberg; G Tajana; G De Rosa; V Sica; G Cirino
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

10.  Over-expression of the thrombin receptor (PAR-1) in the placenta in preeclampsia: a mechanism for the intersection of coagulation and inflammation.

Authors:  Offer Erez; Roberto Romero; Sung-Su Kim; Jung-Sun Kim; Yeon Mee Kim; Derek E Wildman; Nandor Gabor Than; Shali Mazaki-Tovi; Francesca Gotsch; Beth Pineles; Juan Pedro Kusanovic; Jimmy Espinoza; Pooja Mittal; Moshe Mazor; Sonia S Hassan; Chong Jai Kim
Journal:  J Matern Fetal Neonatal Med       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.